MEDICLINIC INTERNATIONAL PLC - Notification of transactions by persons discharging managerial responsibilities and persons closely associated

Notification of transactions by persons discharging managerial responsibilities and persons closely associated

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(‘Mediclinic’, or the ‘Company’, or the ‘Group’)

6 December 2022

        NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
          RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.    Details of persons discharging managerial responsibilities (‘PDMR’) / persons closely
      associated with them (‘PCA’)

a)    Name                     Koert Pretorius

2.    Reason for the notification
a)    Position / status        Group Chief Operating Officer – Mediclinic International plc
b)    Initial notification /   Initial notification
      amendment

3.    Details of the issuer, emission allowance market participant, auction platform, auctioneer or
      auction monitor

a)    Name                     Mediclinic International plc
b)    LEI                      2138002S5BSBIZTD5I60

4.    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
      type of transaction; (iii) each date; and (iv) each place where transactions have been
      conducted

a)    Description of the       Ordinary shares
      financial instrument

      Identification Code      GB00B8HX8Z88

b)    Nature of the            Sale of shares
      transaction

c)    Price(s) and
      volume(s)                Price(s)                       Volume(s)
                               ZAR 104.21                     75 000
d)    Aggregated
      information

      Aggregated volume        75 000
      Price                    ZAR 104.21 per share

e)    Date of the              5 December 2022
      transaction

f)    Place of the             Johannesburg Stock Exchange
      transaction

ABOUT MEDICLINIC INTERNATIONAL PLC

Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with
divisions in Switzerland, Southern Africa (South Africa and Namibia) and the Middle East.

The Group’s core purpose is to enhance the quality of life.

Its vision is to be the partner of choice that people trust for all their healthcare needs.

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in
such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by
patients, medical practitioners, funders and regulators of healthcare in each of its markets.

At 30 September 2022, Mediclinic comprised 74 hospitals, five subacute hospitals, three mental health facilities,
21 day case clinics and 23 outpatient clinics. Hirslanden operated 17 hospitals and five day case clinics in
Switzerland with around 1 900 inpatient beds; Mediclinic Southern Africa operations included 50 hospitals (three
of which in Namibia), five subacute hospitals, three mental health facilities and 14 day case clinics (four of which
operated by Intercare) across South Africa, and around 8 700 inpatient beds; and Mediclinic Middle East operated
seven hospitals, two day case clinics and 23 outpatient clinics with around 1 000 inpatient beds in the UAE. In
addition, under management contract Mediclinic Middle East will open a 200-bed hospital in the Kingdom of Saudi
Arabia in 2023.

The Company’s primary listing is on the London Stock Exchange (‘LSE’) in the United Kingdom, with secondary
listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia.

Mediclinic also holds a 29.7% (2022: 29.9%) interest in Spire Healthcare Group plc, a leading private healthcare
group based in the United Kingdom and listed on the LSE.

CONTACT INFORMATION
Investor queries
James Arnold, Head of Investor Relations, Mediclinic International plc
+44 (0)20 3786 8181
ir@mediclinic.com

Media queries
FTI Consulting
Ben Atwell/Ciara Martin – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Ltd)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd

Date: 06-12-2022 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.